SCHEMBL7856313

SCHEMBL7856313

Brc1cccc(Nc2cc(NC3CCNCC3)ncn2)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 1/20 0.49
EGFR P00533 5/20 0.48
ERBB3 P21860 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPK1 P28482 1/20 0.42
PRKCQ Q04759 1/20 0.41
AURKA O14965 1/20 0.41
AURKB Q96GD4 1/20 0.41
INCENP Q9NQS7 1/20 0.41
HRH4 Q9H3N8 2/20 0.41
HRH3 Q9Y5N1 2/20 0.41
HRH2 P25021 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27330845 0.91 TNNI3K (0.54) TNNI3KEGFRERBB3AURKAAURKB
SCHEMBL7852421 0.86 IDH2 (0.47) TNNI3KEGFRERBB3MAPK1AURKA
SCHEMBL8801375 0.85 EGFR (0.51) TNNI3KEGFRERBB3AURKAAURKB
SCHEMBL8801381 0.85 EGFR (0.51) TNNI3KEGFRERBB3AURKAAURKB
SCHEMBL8798907 0.85 EGFR (0.52) TNNI3KEGFRALDH1A1CYP1A2CYP3A4
SCHEMBL27338343 0.80 CTSL (0.58) TNNI3KEGFRALDH1A1
SCHEMBL8799771 0.80 TNNI3K (0.56) TNNI3KEGFRERBB3CYP1A2CYP3A4
SCHEMBL8800460 0.80 EGFR (0.55) TNNI3KEGFRERBB3CYP1A2CYP2C9
SCHEMBL8799768 0.80 TNNI3K (0.56) TNNI3KEGFRERBB3CYP1A2CYP3A4
SCHEMBL27345374 0.79 KMO (0.49) ALDH1A1CYP1A2CYP3A4CYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163242-A2 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM Boehringer Ingelheim Pharma KG (DE) 2001-12-19 EP disclosed
WO-2000055162-A2 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-21 WO disclosed